Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001140361-26-007148
Filing Date
2026-02-27
Accepted
2026-02-27 16:15:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC14D9C ef20066670_sc14d9c.htm SC14D9C 5511
  Complete submission text file 0001140361-26-007148.txt   7795
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filed by) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Subject) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-34343 | Film No.: 26700075
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)